Endonovo Therapeutics, Inc.
ENDV· OTC
ENDVEndonovo Therapeutics, Inc.
Filed Apr 6, 2018 · 10-K · 96 days after period end · 0001493152-18-004879
derived · Computed from the longer spans the company filed.
| Metric | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | — | $0.00 | — |
| Net Income | $1.77M | -$739.83K | -$4.45M | -$222.93K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Endonovo Therapeutics, Inc. · CIK 1528172 · Engraved from SEC EDGAR
ended Dec 31, 2017 · filed Apr 6, 2018 · 96 d after period end
